Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05853575
Title Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Providence Medical Foundation RECRUITING Santa Rosa California 95403 United States Details
Durham VA Medical Center RECRUITING Durham North Carolina 27705 United States Details
VA North Texas Healthcare System/Dallas VA Medical Center RECRUITING Dallas Texas 75216-7167 United States Details
APHM Hopital Nord RECRUITING Marseille France Details
National Cancer Center RECRUITING Goyang-si Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul Korea, Republic of Details
China Medical University Hospital - Internal Medicine RECRUITING Taichung City Taiwan Details
Ankara Liv Hospital Tibbi Onkoloji RECRUITING Ankara Turkey Details
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi RECRUITING Ankara Turkey Details
Gulhane Egitim ve Arastirma Hastanesi tibbi Onkoloji Klinigi RECRUITING Ankara Turkey Details
Memorial Ankara Hastanesi Tibbi Onkoloji RECRUITING Ankara Turkey Details
Trakya Universitesi Hastanesi Ic Hastaliklari Anabilim Dali Tibbi Onkoloji RECRUITING Edirne Turkey Details
Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi Tibbi Onkoloji RECRUITING Istanbul Turkey Details
Istanbul Onkoloji Hastanesi Tibbi Onkoloji RECRUITING Istanbul Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field